AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Insulet to Present at 38th Annual J.P. Morgan Healthcare Conference

December 20, 2019 GMT

ACTON, Mass.--(BUSINESS WIRE)--Dec 20, 2019--

Insulet Corporation (NASDAQ: PODD) (Insulet), the global leader in tubeless insulin pump technology with its Omnipod ® Insulin Management System, today announced that management will present at the 38 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on January 14, 2020 at 11:00 a.m. (Pacific Time).

To listen to the live audio webcast of the presentation, please visit http://investors.insulet.com. A replay of the webcast will also be available following the event.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company dedicated to making the lives of people with diabetes and other conditions easier through the use of its Omnipod product platform. The Omnipod Insulin Management System provides a unique alternative to traditional insulin delivery methods. With its simple, wearable design, the disposable Pod provides up to three days of non-stop insulin delivery, without the need to see or handle a needle. Insulet also leverages the unique design of its Pod by tailoring its Omnipod technology platform for the delivery of non-insulin subcutaneous drugs across other therapeutic areas. For more information, please visit: www.insulet.com and www.myomnipod.com.

View source version on businesswire.com:https://www.businesswire.com/news/home/20191220005019/en/

CONTACT: Investor Relations and Media Contacts:

Deborah R. Gordon

Vice President, Investor Relations and Corporate Communications

(978) 600-7717

dgordon@insulet.comMichael True

Senior Manager, Investor Relations

(978) 600-7226

mtrue@insulet.com

KEYWORD: CALIFORNIA MASSACHUSETTS UNITED STATES NORTH AMERICA

INDUSTRY KEYWORD: DIABETES PHARMACEUTICAL HEALTH MEDICAL DEVICES

SOURCE: Insulet Corporation

Copyright Business Wire 2019.

PUB: 12/20/2019 07:00 AM/DISC: 12/20/2019 07:01 AM

http://www.businesswire.com/news/home/20191220005019/en